Editorial: Harnessing chemotherapy resistance and development of novel therapeutic strategies for acute leukemia with KMT2A (MLL)-gene rearrangements

Detalles Bibliográficos
Autores principales: Esposito, Maria Teresa, Hagström-Andersson, Anna, Stam, Ronald W., Bortoluzzi, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393731/
https://www.ncbi.nlm.nih.gov/pubmed/36003510
http://dx.doi.org/10.3389/fphar.2022.977741
_version_ 1784771334614548480
author Esposito, Maria Teresa
Hagström-Andersson, Anna
Stam, Ronald W.
Bortoluzzi, Stefania
author_facet Esposito, Maria Teresa
Hagström-Andersson, Anna
Stam, Ronald W.
Bortoluzzi, Stefania
author_sort Esposito, Maria Teresa
collection PubMed
description
format Online
Article
Text
id pubmed-9393731
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93937312022-08-23 Editorial: Harnessing chemotherapy resistance and development of novel therapeutic strategies for acute leukemia with KMT2A (MLL)-gene rearrangements Esposito, Maria Teresa Hagström-Andersson, Anna Stam, Ronald W. Bortoluzzi, Stefania Front Pharmacol Pharmacology Frontiers Media S.A. 2022-08-08 /pmc/articles/PMC9393731/ /pubmed/36003510 http://dx.doi.org/10.3389/fphar.2022.977741 Text en Copyright © 2022 Esposito, Hagström-Andersson, Stam and Bortoluzzi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Esposito, Maria Teresa
Hagström-Andersson, Anna
Stam, Ronald W.
Bortoluzzi, Stefania
Editorial: Harnessing chemotherapy resistance and development of novel therapeutic strategies for acute leukemia with KMT2A (MLL)-gene rearrangements
title Editorial: Harnessing chemotherapy resistance and development of novel therapeutic strategies for acute leukemia with KMT2A (MLL)-gene rearrangements
title_full Editorial: Harnessing chemotherapy resistance and development of novel therapeutic strategies for acute leukemia with KMT2A (MLL)-gene rearrangements
title_fullStr Editorial: Harnessing chemotherapy resistance and development of novel therapeutic strategies for acute leukemia with KMT2A (MLL)-gene rearrangements
title_full_unstemmed Editorial: Harnessing chemotherapy resistance and development of novel therapeutic strategies for acute leukemia with KMT2A (MLL)-gene rearrangements
title_short Editorial: Harnessing chemotherapy resistance and development of novel therapeutic strategies for acute leukemia with KMT2A (MLL)-gene rearrangements
title_sort editorial: harnessing chemotherapy resistance and development of novel therapeutic strategies for acute leukemia with kmt2a (mll)-gene rearrangements
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393731/
https://www.ncbi.nlm.nih.gov/pubmed/36003510
http://dx.doi.org/10.3389/fphar.2022.977741
work_keys_str_mv AT espositomariateresa editorialharnessingchemotherapyresistanceanddevelopmentofnoveltherapeuticstrategiesforacuteleukemiawithkmt2amllgenerearrangements
AT hagstromanderssonanna editorialharnessingchemotherapyresistanceanddevelopmentofnoveltherapeuticstrategiesforacuteleukemiawithkmt2amllgenerearrangements
AT stamronaldw editorialharnessingchemotherapyresistanceanddevelopmentofnoveltherapeuticstrategiesforacuteleukemiawithkmt2amllgenerearrangements
AT bortoluzzistefania editorialharnessingchemotherapyresistanceanddevelopmentofnoveltherapeuticstrategiesforacuteleukemiawithkmt2amllgenerearrangements

Ejemplares similares